Latest Innovation News

Ionic Rare Earths advances its global rare earths strategy with significant UK government funding, increased heavy rare earth oxide production, and a $15.6 million capital raise backed by a strategic US investor.

L1 Group has completed its merger with Platinum Asset Management, forming a $16.9 billion investment powerhouse focused on stabilising funds under management and unlocking significant cost synergies.

Locate Technologies reports a 19% revenue increase in its Locate2u segment and progresses toward a December 2025 NZX listing, supported by new board appointments and a NZD 10 million ATM facility.

Archer Materials has successfully demonstrated that its blood potassium Biochip can be fabricated on a silicon platform, matching clinical accuracy standards and accelerating its path to commercialisation.

Doctor Care Anywhere reports a 7.5% rise in consultations excluding secondary care and sustains positive cashflow for the second consecutive quarter, reaffirming ambitious medium-term growth targets.

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.

INOVIQ Limited has raised $9.5 million to advance its pioneering ovarian cancer screening test and CAR-exosome therapeutic programs, backed by strong preclinical data and strategic partnerships.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.

Nexus Minerals has reported significant new high-grade gold discoveries at its Wallbrook Gold Project, alongside progress in permitting its Crusader-Templar deposit for mining operations.

Iondrive Limited has advanced its battery recycling ambitions by securing key partnerships in the US and Australia, commencing pilot plant construction, and gaining substantial government funding support.

Hawsons Iron Limited has reported positive Phase 1 results from a CSIRO study revealing the mineral composition of its iron tailings, highlighting potential for hematite recovery as a valuable byproduct.

MyEco Group reported a modest 2% sales increase in Q1 FY26, driven by strong council channel growth that offsets U.S. tariff-related setbacks. Operational restructuring and regulatory tailwinds underpin its medium-term outlook.